Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival - PubMed (original) (raw)
Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival
Nirmitha I Herath et al. BMC Cancer. 2006.
Abstract
Background: Increased expression of Eph receptor tyrosine kinases and their ephrin ligands has been implicated in tumor progression in a number of malignancies. This report describes aberrant expression of these genes in ovarian cancer, the commonest cause of death amongst gynaecological malignancies.
Methods: Eph and ephrin expression was determined using quantitative real time RT-PCR. Correlation of gene expression was measured using Spearman's rho statistic. Survival was analysed using log-rank analysis and (was visualised by) Kaplan-Meier survival curves.
Results: Greater than 10 fold over-expression of EphA1 and a more modest over-expression of EphA2 were observed in partially overlapping subsets of tumors. Over-expression of EphA1 strongly correlated (r = 0.801; p < 0.01) with the high affinity ligand ephrin A1. A similar trend was observed between EphA2 and ephrin A1 (r = 0.387; p = 0.06). A striking correlation of both ephrin A1 and ephrin A5 expression with poor survival (r = -0.470; p = 0.02 and r = -0.562; p < 0.01) was observed. Intriguingly, there was no correlation between survival and other clinical parameters or Eph expression.
Conclusion: These data imply that increased levels of ephrins A1 and A5 in the presence of high expression of Ephs A1 and A2 lead to a more aggressive tumor phenotype. The known functions of Eph/ephrin signalling in cell de-adhesion and movement may explain the observed correlation of ephrin expression with poor prognosis.
Figures
Figure 1
Transcript number of Eph and ephrin genes in non-malignant (N) and tumorigenic (T) tissues, relative to 108 copies of 18S rRNA shown on a log scale. Whiskers show the 10th–90th percentile range while the shaded areas show the 25th–75th percentile range. The thin and heavy horizontal lines represent the median and the mean respectively.
Figure 2
Plots showing association between high and low levels of ephrin A1 or ephrin A5, in conjunction, with survival.
Similar articles
- The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y, Du Z, Mou J, Qiu X, Chen J, Cai S, Ren D, Xiao F, Zhou G, Yuan C. Wu Y, et al. Curr Med Chem. 2023;30(20):2340-2353. doi: 10.2174/0929867329666220820125638. Curr Med Chem. 2023. PMID: 35996244 Review. - The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z. Han L, et al. Gynecol Oncol. 2005 Nov;99(2):278-86. doi: 10.1016/j.ygyno.2005.06.036. Epub 2005 Aug 2. Gynecol Oncol. 2005. PMID: 16061279 - Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.
Reissenweber B, Mosch B, Pietzsch J. Reissenweber B, et al. Melanoma Res. 2013 Apr;23(2):85-95. doi: 10.1097/CMR.0b013e32835e58f3. Melanoma Res. 2013. PMID: 23358429 - Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI, Steiner AA, Scheck AC, Romanovsky AA. Ivanov AI, et al. Physiol Genomics. 2005 Apr 14;21(2):152-60. doi: 10.1152/physiolgenomics.00043.2004. Epub 2005 Jan 25. Physiol Genomics. 2005. PMID: 15671251 - Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K, Maru Y. Ieguchi K, et al. Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15. Cancer Sci. 2019. PMID: 30657619 Free PMC article. Review.
Cited by
- Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang X, Liu Y, Cao G, Zhang X, Xu H, Xu H, Wang J. Wang X, et al. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6821-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261568 Free PMC article. - Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.
Wu JC, Sun BS, Ren N, Ye QH, Qin LX. Wu JC, et al. J Cancer Res Clin Oncol. 2010 Apr;136(4):595-601. doi: 10.1007/s00432-009-0695-0. Epub 2009 Oct 16. J Cancer Res Clin Oncol. 2010. PMID: 19834740 - Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
Holm R, de Putte GV, Suo Z, Lie AK, Kristensen GB. Holm R, et al. Int J Med Sci. 2008 Jun 5;5(3):121-6. doi: 10.7150/ijms.5.121. Int J Med Sci. 2008. PMID: 18566674 Free PMC article. - EphA receptor signaling--complexity and emerging themes.
Miao H, Wang B. Miao H, et al. Semin Cell Dev Biol. 2012 Feb;23(1):16-25. doi: 10.1016/j.semcdb.2011.10.013. Epub 2011 Oct 21. Semin Cell Dev Biol. 2012. PMID: 22040915 Free PMC article. Review. - EphA2 is a critical oncogene in melanoma.
Udayakumar D, Zhang G, Ji Z, Njauw CN, Mroz P, Tsao H. Udayakumar D, et al. Oncogene. 2011 Dec 15;30(50):4921-9. doi: 10.1038/onc.2011.210. Epub 2011 Jun 13. Oncogene. 2011. PMID: 21666714 Free PMC article.
References
- Boyd AW, Lackmann M. Signals from Eph and ephrin proteins: a developmental tool kit. Sci STKE. 2001;RE20 - PubMed
- Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DJ, Pawson T, Davis S, Yancoupoulos GD. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalised during embryogenesis. Neuron. 1996;17:9–19. doi: 10.1016/S0896-6273(00)80276-7. - DOI - PubMed
- Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF, Boyd AW. The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int J Dev Biol. 2002;46:375–384. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous